Wave Life Sciences, Inc.

US$3.37As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:WVEHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (20.09%)
Div yield —
ROE (78.80%)
Biotechnology
Beta (5Y) (1.44)
PE TTM —
TSR TTM (62.78%)
Mkt cap US$663.7M
ROIC (47.63%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$3.32
(1.21%)
(80.09%)
Hold 6|12|6|1|7
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.04
0.04
0.03
0.04
18.19%
5.39%
(7.59%)
(4.27%)
Revenue$M
82.05
83.41
84.94
88.62
7.77%
10.80%
6.78%
13.36%
Peers (US$663.7M)
Cap (US$)
PE
662.9M
18.20x
Capital
TTM
5Y
10Y
Leveragex
0.361
(0.573)
(0.406)
EBIT/Intx
1.270
0.257
0.204
Own earn%
(19.59)
135.68
111.92
Sh yield%
47.22
27.79
25.33
Owners
Insiders/Inst%
0.85
27.86
Short interest%
3.71
SBC / revenue%
2.03
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
20
Op margin range%
10–17
$1 testx
−0.1
Incr. ROIC%
12